Investor Presentaiton

Investor presentation Full year 2018 The GLP-1 segment accounts for around 6% of the total diabetes care market in Region Latin America Region Latin America GLP-1 market VictozaⓇ value market share in Region Latin America DKK billion VictozaⓇ Exenatide Dulaglutide Other GLP-1 market value Share of total diabetes care GLP-1 value market share market 100% 1 0.7 6% 0.6 CAGR value¹: 10.8% 5% 80% 0.5 4% 60% 0.4 3% 0.3 40% 2% 0.2 20% 0.1 1% 0.0 0% 0% Nov 2013 Nov 2018 Nov 2013 1 CAGR for 5-year period Source: IQVIA monthly MAT Nov, 2018 value figures changing diabetes Source: IQVIA monthly MAT Nov, 2018 value figures Slide 80 VictozaⓇ Exenatide Dulaglutide Other .68% 31% 1% Nov 2018 novo nordisk

View entire presentation